logo
15:59 Dec 05

NGL Fine - Chem Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1299.50
-3.70 (-0.28%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NGL Fine - Chem Ltd. Financials

NGL Fine - Chem Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1299.50
-3.70 (-0.28%)
15:59 Dec 05
Quality
image/svg+xml

48/100
Medium Financial Strength

Valuation
image/svg+xml

40/100
Mid Valuation

Technical

46/100
Technically Neutral

Strength

6

Weakness

3

Opportunity

0

Threats

0

7.47 %

ROE %

4.87 %

ROA %

33.48

EPS

457.16

BVPS

5.73 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
317.5 278.08 338.69 368.26 408.52
Operating Expenses +
249.66 243.76 285.42 334.39 368.97
Raw Material
169.67 116.41 170.81 182.41 216.4
Increase Decrease in Cost
-22.68 23.91 -12.13 -0.01 -15.91
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
34.85 36.87 45.12 55.55 60.37
Miscellaneous Expenses
67.82 66.57 81.62 96.44 108.11
Operating Profit
67.84 34.32 53.27 33.87 39.55
Other Income
10.68 5.53 14.13 8.63 7.3
Depreciation
10.37 11.29 11.64 12.45 15.77
Interest
1.56 1.2 1.34 2.33 3.95
Profit before tax and exceptio..
66.6 27.36 54.42 27.71 27.13
Exceptional Items
0 0 0 0 0
PBT
66.6 27.36 54.42 27.71 27.13
Provision for Taxation
16.7 6.87 13.1 6.59 6.45
Net Profit
49.9 20.5 41.32 21.12 20.69
NET Profit after MI
49.9 20.5 41.32 21.12 20.69
EPS
80.77 33.18 66.88 34.19 33.49
Operating Profit Margin (%)
21.37 12.34 15.73 9.2 9.68
Net Profit Margin (%)
15.72 7.37 12.2 5.74 5.06

NGL Fine - Chem Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 72.70 72.70 72.70 72.70 72.70 72.70
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 27.30 27.30 27.30 27.30 27.30 27.30
Shareholder Shares Holding %
Research 360 logo
Download Our App On: